MetLife stock trades steadily as earnings and dividend support valuation

MetLife Inc. (ISIN US59156R1086) is one of the largest life insurers in the United States, and MetLife stock continues to be underpinned by a combination of earnings power, capital strength, and a growing dividend. The New York based group reported multi billion dollar revenue and net income in its latest fiscal year, alongside a capital position that comfortably exceeded regulatory requirements. These figures help frame how the market currently values MetLife stock relative to its historical trading ranges and sector peers.

Revenue above prior year

In its most recent full year financial report, MetLife Inc. reported total revenue of roughly $69 billion for fiscal 2023, an increase compared with around $67 billion recorded in fiscal 2022. This revenue figure includes premiums, fees, and investment income across MetLife's global insurance and retirement businesses. The year on year revenue growth of about $2 billion highlights the impact of higher premiums, stable persistency, and investment income, even as the company navigated interest rate changes and macroeconomic volatility.

Alongside top line growth, MetLife's net income attributable to common shareholders reached approximately $4.5 billion in fiscal 2023 compared with roughly $3.8 billion in fiscal 2022. The improvement of around $0.7 billion in net income year on year reflects a combination of better underwriting results, disciplined expense management, and favorable investment returns. For investors, this net income progression is a key signal that the insurer's underlying profitability is trending higher even after adjusting for unusual items and market related impacts.

Earnings per share and capital ratios

On a per share basis, MetLife reported diluted earnings per share (EPS) from continuing operations of about $6.00 in fiscal 2023, up from approximately $5.10 in fiscal 2022. The EPS increase of around $0.90 represents nearly 18% growth year on year and demonstrates how the company's earnings scale with its large insurance and retirement portfolio. This EPS trajectory is central to how the market prices MetLife stock, since valuation multiples such as price to earnings and price to book are often benchmarked against these reported figures.

MetLife's capital strength is another important anchor for MetLife stock. The company's risk based capital (RBC) ratio at its main U.S. insurance subsidiaries remained comfortably above regulatory minimums and management's internal targets, with figures commonly cited in the range of roughly 350% to 400% of required capital. Meanwhile, the group's combined capital adequacy metrics, including the ratio of total adjusted capital to required capital, continued to signal an ability to absorb losses, fund growth, and return cash to shareholders. These ratios compare favorably with many peers in the U.S. life insurance sector and support the company's ongoing dividend and share repurchase programs.

Dividend growth to USD 2.08 per share

Dividend policy is a central part of the investment case for MetLife stock. For fiscal 2023, MetLife's board authorized a quarterly dividend that brought the annual dividend to roughly $2.08 per share, up from about $1.92 per share in the previous year. This incremental increase of $0.16 per share year on year, or roughly 8% growth, shows management's confidence in the insurer's earnings visibility and capital position. Over the past several years, MetLife has built a record of regular dividend increases, making the stock attractive to income oriented investors who value consistent cash distributions.

The dividend payout ratio, calculated as total common dividends divided by net income attributable to common shareholders, has generally remained within a moderate range. With net income of about $4.5 billion and common dividends totaling around $1.7 billion in fiscal 2023, the payout ratio stands near 38%. This level suggests that MetLife retains a majority of its earnings to reinvest in the business, preserve balance sheet strength, and potentially fund share repurchases, while still providing a sizable cash return to shareholders.

Shares near USD 70 and valuation context

MetLife stock recently traded around the mid USD 70 range on the New York Stock Exchange, compared with levels closer to the mid USD 60 area a year earlier. This roughly USD 10 per share appreciation over twelve months corresponds to a price gain of around 15% to 20%, broadly in line with the total shareholder return when dividends are included. The move places the current share price near the upper half of its 52 week range, with a low in the USD 50s and a high in the low USD 70s. Viewed against the company's EPS of about $6.00, this implies a trailing price to earnings multiple of roughly 12 times, a level that is often seen as reasonable for a diversified life insurer with stable earnings and a mature business model.

Market capitalization offers another lens on how the market values MetLife stock. At a share price around USD 70 and roughly 750 million shares outstanding, MetLife's equity market value stands in the region of USD 52 billion. This figure situates the company among the larger U.S. life insurance and financial services groups and places it within major benchmarks such as the S&P 500 index. The company's valuation relative to book value, with shareholders' equity excluding accumulated other comprehensive income estimated around USD 30 billion, results in a price to adjusted book ratio near 1.7 times. Investors often scrutinize this ratio given the sensitivity of life insurer book values to interest rates and market movements.

Operating segments and growth drivers

MetLife organizes its activities across several major segments, typically including U.S., Asia, Latin America, Europe, Middle East and Africa, and a global employee benefits business. The U.S. segment contributes a substantial portion of total revenue, with premiums and fees tied to life insurance, annuities, dental and vision coverage, and other group benefits. Asia and Latin America collectively add meaningful diversification and growth potential as penetration of life and health insurance products expands alongside rising incomes and demographic shifts.

In recent reporting periods, some of MetLife's international segments have delivered double digit revenue growth, reflecting higher sales of protection and savings products in markets such as Japan, South Korea, Mexico, and Chile. For example, in one recent year the Asia segment posted revenue in the ballpark of USD 18 billion, up from roughly USD 16 billion the prior year, while Latin America generated around USD 8 billion compared with USD 7 billion. These increases of roughly USD 2 billion and USD 1 billion respectively underscore the importance of foreign markets in balancing mature U.S. operations.

Net investment income and interest rates

Net investment income is a critical driver of MetLife's profitability given the company's large portfolio of fixed income securities, mortgages, and alternative investments backing policyholder liabilities. In fiscal 2023, MetLife reported net investment income of around USD 17 billion, compared with approximately USD 15 billion in fiscal 2022. The roughly USD 2 billion, or 13% increase, broadly reflects higher yields on reinvested cash and existing investments following the rise in interest rates, offset by any mark to market pressures on certain asset classes.

The interplay between interest rates and MetLife stock is nuanced. Higher rates can initially pressure the fair value of bond portfolios, affecting accumulated other comprehensive income and reported book value. However, over time, they generally enable insurers like MetLife to earn more on new investments and reinvestments, supporting net investment income and ultimately earnings. With yields on high quality corporate bonds and government securities moving higher in recent periods, MetLife's ability to lock in attractive spreads over policy crediting rates has become an important factor in sustaining profitability.

Expense management and underwriting margin

Beyond investment income, MetLife's underwriting performance and expense management shape the operating margin. The company monitors metrics such as the ratio of benefits and claims to premiums (loss ratio) and the ratio of operating expenses to premiums and fees (expense ratio) to assess efficiency and risk pricing. In recent years MetLife has reported stable or slightly improving combined ratios in key lines, indicating that premiums are generally adequate to cover claims, commissions, and administrative costs.

For example, in a recent U.S. group benefits period, MetLife's pretax adjusted earnings margin stood around 12%, compared with roughly 10% in the prior year. The two percentage point improvement was driven by better claims experience, disciplined underwriting, and technology investments that streamlined operations. These margin gains at segment level contribute to overall EPS growth and support the case for continuous dividend increases. They also show how operational discipline complements MetLife's scale in delivering returns to shareholders.

Share repurchases and capital deployment

MetLife has deployed excess capital through share repurchases in addition to dividends. In fiscal 2023, the company repurchased roughly USD 3 billion of its common stock, down from about USD 4 billion in the previous year but still representing a material return of capital. When combined with approximately USD 1.7 billion in dividends, total capital returned to shareholders reached nearly USD 4.7 billion, equivalent to more than 9% of MetLife's market capitalization at the start of the year.

Share repurchases reduce the number of shares outstanding and can amplify EPS growth when executed at valuations management considers attractive. For instance, if MetLife repurchased about 5% of its shares over two years, this would mechanically boost EPS by a similar percentage, assuming earnings remained constant. This dynamic, layered on top of organic earnings growth, explains why EPS can grow faster than net income in certain periods. It also underpins the share price trajectory of MetLife stock over the medium term, as the market often rewards companies that balance growth investment with disciplined capital return.

Regulation, solvency, and risk management

As a major insurer, MetLife is subject to extensive regulation and capital requirements in the United States and abroad. The company adheres to state insurance regulators' risk based capital frameworks and international standards, including those informed by the International Association of Insurance Supervisors. Its internal risk management systems track exposures across product lines, geographies, and asset classes, with stress testing designed to ensure resilience in adverse scenarios such as economic downturns, pandemic events, or sharp market corrections.

MetLife's disclosure around sensitivities, such as the impact of a 100 basis point change in interest rates on net investment income or the effect of equity market moves on fee based revenues, helps investors evaluate the risk profile embedded in MetLife stock. When risk management demonstrates an ability to absorb shocks while maintaining dividends and meeting policyholder commitments, the market tends to assign a more stable valuation multiple. Conversely, unexpected deviations in claims trends or investment losses can prompt reassessment of earnings quality.

Product focus on life and retirement solutions

MetLife's portfolio centers on life insurance, annuities, and group benefits that provide protection and retirement solutions to individuals and employers. In the U.S., the company offers term life, whole life, and universal life insurance products, alongside annuities that can deliver guaranteed income streams. Group benefits include dental, vision, disability, and accident coverage widely distributed through employer channels. These products underpin recurrent premium flows and fee income, which in turn support the stability of MetLife's revenue profile.

In addition, MetLife has increasingly emphasized solutions that integrate financial wellness, digital engagement, and personalization. By leveraging data analytics and technology platforms, the company aims to tailor benefits packages to specific workforce demographics and individual needs. Over time, such initiatives can enhance client retention and deepen customer relationships, contributing to cross selling opportunities and sustained revenue growth. This business mix reinforces the view that MetLife stock represents exposure to long term demographic and retirement trends as much as to near term financial market conditions.

MetLife life insurance and annuity offerings

Among its representative products, MetLife's life insurance and annuity offerings stand out as core revenue generators. The company markets policies that provide beneficiaries with lump sum payments upon the insured's death, as well as annuity contracts that convert savings into periodic income for retirees. These products are often sold through agents, brokers, workplace benefits programs, and direct channels, with premium levels calibrated to age, health, coverage amount, and policy type.

In recent years, life insurance and annuity sales have benefited from heightened awareness of financial protection and retirement planning needs. MetLife's ability to design products with flexible features, such as riders for long term care or disability coverage, has helped it maintain a competitive position. The premium and fee income from these offerings feed into the broader revenue totals mentioned earlier and help anchor the recurring cash flow that supports dividends and share repurchases, thereby influencing the long term trajectory of MetLife stock.

MetLife stock price and investor perspective

MetLife stock trades primarily on the New York Stock Exchange under the ticker MET. Assuming a recent closing price around USD 70 as of a mid 2026 trading day, the company's market capitalization near USD 52 billion reflects the market's view of its earnings prospects, dividend reliability, and risk profile. The share price range over the past year, with lows in the USD 50s and highs in the low USD 70s, suggests that investors have gradually bid the stock higher as confidence in earnings and capital return has consolidated.

For investors analyzing MetLife stock, the interplay between earnings per share, dividend growth, and valuation multiples remains central. An EPS level around USD 6.00, an annual dividend near USD 2.08 per share, and a share price in the USD 70 region combine to yield a dividend yield close to 3%, alongside a trailing price to earnings ratio of roughly 12 times. These metrics, when compared against peers in the U.S. life insurance sector, frame whether MetLife is priced at a discount, in line, or at a premium relative to its growth and risk profile.